Champions Oncology, Inc. (CSBR) vs Citius Oncology, Inc. (CTOR)
A side-by-side comparison of Champions Oncology, Inc. and Citius Oncology, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CSBR
Champions Oncology, Inc.
$5.01HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
CTOR
Citius Oncology, Inc.
$0.85HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — CSBR vs CTOR
growth of $100 · dividends reinvested · last 2yCSBR +1.4% (+0.7%/yr)CTOR -92.4% (-72.4%/yr)CSBR compounded faster over this window
Log scale — wide-divergence pair
CSBR CTOR
CSBR vs CTOR: by the numbers
- •CTOR is the larger company ($79M vs $70M market cap).
- •Both run net losses; CSBR's is the smaller (-1.87% vs -648.32% net margin).
Metrics side by side
Valuation
| Metric | CSBR | CTOR |
|---|---|---|
| Forward P/E | 50.10 | 8.50 |
| P/S ratio | 1.15 | 11.12 |
| P/B ratio | 17.88 | 1.96 |
| EV / EBITDA | 261.92 | N/A |
Profitability
| Metric | CSBR | CTOR |
|---|---|---|
| Gross margin | 49.30% | 0.00% |
| Operating margin | -1.72% | 0.00% |
| Net margin | -1.87% | -648.32% |
| ROE | -29.15% | -114.06% |
| ROIC | -6.75% | -88.72% |
Growth (annualized)
| Metric | CSBR | CTOR |
|---|---|---|
| Revenue CAGR (5Y) | 7.25% | N/A |
| Total return CAGR (5Y) | -13.07% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.